AIM ImmunoTech Stock Forum

$AIM ImmunoTech(AIM.US)$
NEWS
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
AIM ImmunoTech Inc. announced promising interim data showing that combining Ampligen with Keytruda in treating recurrent ovarian cancer could have a powerful synergistic effect, significantly increasing response rates and progression-free survival. The study also highlighted increased an...

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions 2 MINUTES AGO, 8:50 AM EST VIA GLOBENEWSWIRE

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer 3 MINUTES AGO, 9:10 AM EST VIA GLOBENEWSWIRE

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca's Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Issued Two US Patents Titled 'Compositions for Cancer Therapy and Methods' And 'Methods for Improving Exercise Tolerance in Myalgic Encephalomyelitis Patients'

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Completes Treatment of Last Subject in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions 12 MINUTES AGO, 12:00 PM EST VIA GLOBENEWSWIRE AIM SHARE No severe adverse events reported to date Topline data expected as early as Q1 2024

$AIM ImmunoTech(AIM.US)$ hmmmmm

$AIM ImmunoTech(AIM.US)$ AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for the Treatment of Advanced Recurrent Ovarian Cancer 1 MINUTE AGO, 8:45 AM EST VIA GLOBENEWSWIRE